Jefferies says Regeneron's Dupixent drug could drive shares 15% higher
Bill Ackman says U.S. economy risks heading into a 'train wreck'
March 23, 2023
Italy to hand Monte dei Paschi CEO Lovaglio new mandate – sources
March 25, 2023
[ad_1]
Regeneron's Dupixent drug could serve as the next big catalyst for shares of the pharmaceutical company, according to Jefferies.
[ad_2]
Source link
